Dapoxetine hydrochloride: Phase III data

Data from 2 identical double-blind, placebo-controlled, U.S. Phase III trials in 2,614 men showed that dapoxetine met the primary endpoint (p<0.0001) and all secondary endpoints compared with placebo....